Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,767,922
+$470,858 QoQ
Shares Held
36,804
+6.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#245
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$402,570
PutShares
3,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $485,897,181 across 15 Drug Manufacturers - General names. NVS ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,252 | $137,037,286 | |
| 2 | ABBV |
AbbVie Inc.
|
459,683 | $115,674,628 | |
| 3 | JNJ |
Johnson & Johnson
|
392,685 | $99,730,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
378,859 | $48,683,381 | |
| 5 | AMGN |
Amgen Inc
|
77,970 | $28,234,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
153,825 | $19,434,249 | |
| 7 | PFE |
Pfizer Inc
|
421,273 | $10,144,251 | |
| 8 | AZN |
Astrazeneca PLC
|
41,103 | $7,793,949 |
All Filings in NVS
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,767,922 | 36,804 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $5,297,064 | 34,678 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,030,295 | 43,739 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $5,526,630 | 43,096 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,630,420 | 30,001 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,797,057 | 16,120 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,574,280 | 16,178 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $402,570 | 3,500 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $1,736,456 | 15,097 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,504,066 | 14,128 | Shares | Sole | 2024-08-15 | |
| 2024-06-30 | $372,610 | 3,500 | Put | Sole | 2024-08-15 | |
| 2024-03-31 | $338,555 | 3,500 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $1,405,292 | 14,528 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $353,395 | 3,500 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $1,308,167 | 12,956 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,232,709 | 12,102 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $356,510 | 3,500 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $1,188,618 | 11,779 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $672,520 | 7,310 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $403,341 | 4,446 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $477,494 | 6,282 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $451,728 | 5,344 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $488,153 | 5,563 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $508,463 | 5,813 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $557,903 | 6,822 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $601,362 | 6,591 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $638,621 | 7,471 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $478,760 | 5,070 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $458,627 | 5,274 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $462,989 | 5,301 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $348,681 | 4,229 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||